Gambro shareholder Investor rejects sale report:
This article was originally published in Clinica
Executive Summary
Swedish investment company Investor has dismissed a report in the Swedish daily newspaper Dagens Industri last week that it was poised to sell its 20% stake in dialysis company Gambro to competitor Baxter. "There is no deal between Investor and Baxter," said Nils Ingvar Lundin, Investor's spokesman. Baxter declined to comment. Last year, the Swedish newspaper published a similar report concerning Gambro and German company Fresenius (see Clinica No 913, p 9).